1.37

0.74% 0.01

Allarity Therapeutics Inc (ALLR)

Overview News Price History Financials Discussions Forecast Stock Split

Allarity Therapeutics Inc stock is traded at $1.37, with a volume of 45,504. It is up +0.74% in the last 24 hours and up +18.10% over the past month. Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.

Previous Close:

$1.36

Open:

$1.41

24h Volume:

45,504

Relative Volume:

0.30

Market Cap:

$21.80M

Revenue:

$345.00K

Net Income/Loss:

$-11.25M

P/E Ratio:

-1.8983

EPS:

-0.7217

Net Cash Flow:

$-16.70M

1W Performance:

-1.44%

1M Performance:

+18.10%

6M Performance:

+62.11%

1Y Performance:

+39.82%

1-Day Range:

$1.35

$1.41

1-Week Range:

$1.255

$1.55

52-Week Range:

$0.7687

$2.35

Allarity Therapeutics Inc Stock (ALLR) Company Profile

Name

Allarity Therapeutics Inc

Sector

Healthcare (1080)

Industry

Biotechnology (604)

Phone

401-426-4664

Address

24 SCHOOL ST., 2ND FLOOR, BOSTON

Employee

Twitter

Next Earnings Date

2026-08-21

Latest SEC Filings

ALLR's Discussions on Twitter

Compare ALLR vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ALLR Allarity Therapeutics Inc	1.37	22.28M	345.00K	-11.25M	-16.70M	-0.7217
VRTX Vertex Pharmaceuticals Inc	505.75	133.25B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.48	82.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.29	54.80B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	203.71	43.99B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	347.48	40.62B	5.76B	514.49M	1.10B	4.4813

Allarity Therapeutics Inc Stock (ALLR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-28-25	Initiated	Ascendiant Capital Markets	Buy

Allarity Therapeutics Inc Stock (ALLR) Latest News

Aug 14, 2026

Allarity Therapeutics, Inc. 2026: Revenue $0 Net income ($3.41M), EPS ($0.21) — 10-Q Summary - TradingView

Aug 14, 2026

Allarity Therapeutics reports Q2 results, cash position By Investing.com - Investing.com Canada

Aug 14, 2026

Allarity Therapeutics (ALLR) adds $20M debt, holds $26.9M cash in Q2 2026 - Stock Titan

Aug 14, 2026

Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready ... - Caledonian Record

Aug 14, 2026

Allarity Therapeutics Reports Second Quarter 2026 Results - GlobeNewswire

Aug 14, 2026

Aug 13, 2026

Allarity Therapeutics Inc expected to post a loss of 25 cents a shareEarnings Preview - TradingView

Aug 13, 2026

Aug 03, 2026

CNSY Stock Price and Chart — NASDAQ:CNSY - TradingView

Aug 03, 2026

Allarity Therapeutics (ALLR) Gains 2.48% as Stock Holds Above Key Support ZoneDividend ETF - dars.gov.et

Aug 03, 2026

Jul 28, 2026